AI, HTA, and the Future of Access: Inside the 12th Annual Kraków HTA Symposium
Explore key insights from the 12th Annual Kraków HTA Symposium covering HTA, reimbursement policy, AI…
Simona ColucciJuly 8, 2026
Dosimetry tells you the dose. It doesn’t tell you the decision.
Learn why absorbed dose data alone isn't enough for radiopharmaceutical dose optimization, and how BED,…
CertaraJuly 7, 2026
Enhancing clinical trials with real-world evidence in pregnancy research
Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…
CertaraJune 26, 2026
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development
Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…
Danielle PillsburyJune 23, 2026
Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling
Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…
CertaraJune 22, 2026
Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices
Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…
CertaraJune 22, 2026
Machine Learning based drug renal clearance predictor development and application
A machine learning QSAR model predicts human renal clearance from simple, easy-to-obtain inputs and sharpens…
CertaraJune 22, 2026
